Cargando…

Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database

PURPOSE: To evaluate the effect of serum alpha-fetoprotein(AFP) on prognosis of patients with hepatocellular carcinoma (HCC) and put forward a proposal to modify BCLC staging system and the recommended treatment of patients with stage C. RESULTS: AFP positive was an independent poor prognostic facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Nan, Gu, Jiajia, Yin, Li, Wu, Jing, Du, Ming-yu, Ding, Kai, Huang, Teng, He, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348400/ https://www.ncbi.nlm.nih.gov/pubmed/27835609 http://dx.doi.org/10.18632/oncotarget.13232

Ejemplares similares

The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
por: Zhang, Jiaxin, et al.
Publicado: (2020)

Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray
por: Wu, Min, et al.
Publicado: (2018)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022)

The Characteristics and Prognosis of Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin Double-Negative Hepatocellular Carcinoma at Baseline in Higher BCLC Stages
por: Nagahara, Takakazu, et al.
Publicado: (2023)

Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy
por: Ma, Wen-jun, et al.
Publicado: (2013)

Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer
por: Sun, Wenhui, et al.
Publicado: (2017)

Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP)
por: Dadfar, Seyed Mohammad Mahdi, et al.
Publicado: (2019)

Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification
por: Yamamoto, Masateru, et al.
Publicado: (2021)

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
por: Kikuchi, Luciana, et al.
Publicado: (2017)

Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection
por: Bird, Thomas G., et al.
Publicado: (2016)

Hereditary Persistence of Alpha-Fetoprotein Is Associated with the −119G>A Polymorphism in AFP Gene
por: Deshpande, Neha, et al.
Publicado: (2017)

Role of Alpha-Fetoprotein (AFP) in Diagnosing Childhood Cancers and Genetic-Related Chronic Diseases
por: Głowska-Ciemny, Joanna, et al.
Publicado: (2023)

Alpha fetoprotein (AFP) participates in the build up of hematopoietic cells in the early embryonic stage: an abortion case observation
por: An, Jianhong, et al.
Publicado: (2019)

Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases
por: Chen, Junyu, et al.
Publicado: (2021)

The Role of Alpha-Fetoprotein (AFP) in Contemporary Oncology: The Path from a Diagnostic Biomarker to an Anticancer Drug
por: Głowska-Ciemny, Joanna, et al.
Publicado: (2023)

Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
por: Wang, Xiaoping, et al.
Publicado: (2018)

Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection
por: Lin, Kongying, et al.
Publicado: (2021)

Tumor-derived alpha-fetoprotein (tAFP) causes immune and metabolic dysfunction in monocyte-derived dendritic cells
por: Santos, Patricia M, et al.
Publicado: (2015)

Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy
por: Sun, Li-Yue, et al.
Publicado: (2022)

MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients
por: Lembeck, Anna L., et al.
Publicado: (2020)

Racial disparities in alpha‐fetoprotein testing and alpha‐fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
por: Wu, Guoyi, et al.
Publicado: (2019)

Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
por: Wei, Zhewen, et al.
Publicado: (2022)

Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit
por: De Paepe, Boel
Publicado: (2023)

α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
por: Mao, Xiang, et al.
Publicado: (2023)

The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma
por: Liu, Shuangchi, et al.
Publicado: (2021)

Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification
por: Vasuri, Francesco, et al.
Publicado: (2019)

Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
por: Kuusela, P., et al.
Publicado: (1987)

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
por: Hanif, Hira, et al.
Publicado: (2022)

The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
por: Hu, Xin, et al.
Publicado: (2022)

Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification
por: Kamiyama, Toshiya, et al.
Publicado: (2017)

Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study
por: Wang, Lei, et al.
Publicado: (2023)

Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma
por: Han, Xue, et al.
Publicado: (2019)

The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma
por: Xu, Ye, et al.
Publicado: (2021)

Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System
por: Wee, Ian J Y, et al.
Publicado: (2022)

Evolution and current status of the subclassification of intermediate hepatocellular carcinoma
por: Yi, Peng-Sheng, et al.
Publicado: (2020)

Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma
por: Zhang, Zhiguo, et al.
Publicado: (2015)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
por: Kim, Jun Young, et al.
Publicado: (2016)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2020)

Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic
por: Melms, Johannes C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8324pv4j734sgof6dbb1v7pub5